Brightonics Imaging has been selected as the lead institution for a flagship project under the pan-ministerial advanced medical device research and development program.
The company will develop next-generation whole-body digital PET (positron emission tomography) and PET-CT systems with a total of 24.3 billion won in government research and development (R&D) support over the next seven years.
The project is a national strategic research and development initiative jointly promoted by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministery of Food and Drug Safety.
Seoul National University Hospital, Sogang University, and KAIST will participate as joint research institutions.
PET is a representative molecular imaging device used for the early diagnosis of cancer, dementia, and cardiovascular disease.
Through this project, Brightonics Imaging plans to develop next-generation digital PET and PET-CT systems with enhanced resolution, sensitivity, and quantitative accuracy.
Lee Jae-sung, CEO of Brightonics Imaging and the principal investigator, said, "Our goal goes beyond simple equipment development to build a next-generation PET platform with world-class performance and price competitiveness," adding, "We will achieve full-cycle technological self-reliance from localization of integrated PET systems to clinical application."
☞PET
A device that detects annihilation radiation emitted from a person injected with a radiopharmaceutical that releases positrons.